Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD4 | P21917 | 16/20 | 1.00 |
| ▸ | DRD2 | P14416 | 7/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | HTR1A | P08908 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6403181 | 0.83 | DRD4 (0.72) | DRD4DRD2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL6402004 | 0.83 | CCR3 (0.82) | DRD4DRD2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL11712058 | 0.83 | DRD4 (0.71) | DRD4DRD2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL15822962 | 0.82 | CYP2C19 (1.00) | DRD4DRD2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL30098940 | 0.82 | CYP2C19 (1.00) | DRD4DRD2CYP1A2CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL6397461 | 0.82 | CCR3 (0.81) | DRD4DRD2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL7596469 | 0.79 | DRD4 (0.68) | DRD4DRD2CYP1A2CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL6396151 | 0.78 | DRD4 (0.67) | DRD4DRD2CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL4521840 | 0.78 | DRD4 (0.77) | DRD4DRD2HTR1A | |
| SCHEMBL9287641 | 0.77 | DRD2 (0.74) | DRD4DRD2CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119842625-A | Cell line for stably expressing orthogonal aminoacyl tRNA synthetase/tRNA pair | 浙江大学 | 2025-04-18 | — | — | CN | claimed |
| CN-118421507-A | Application of medical cell CMU-Pb-12 combined dexamethasone in preparation of psoriasis prevention and treatment drugs | 广东行海生物科技有限公司 | 2024-08-02 | — | — | CN | claimed |
| US-20260139009-A1 | PREFUSION-STABILIZED CMV GB PROTEINS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260062742-A1 | RECOMBINANT LIGASES AND USES THEREOF | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-03-05 | — | — | US | disclosed |
| CN-119842625-A | Cell line for stably expressing orthogonal aminoacyl tRNA synthetase/tRNA pair | 浙江大学 | 2025-04-18 | — | — | CN | disclosed |
| EP-4497741-A1 | ORGANIC FERTILIZER FROM STERILIZED AND DRIED INSECT FRASS, ESPECIALLY FROM HERMETIA ILLUCENS, ITS APPLICATIONS AND METHODS OF FERTILIZATION AND IMPROVEMENT OF SOIL MOISTURE USING IT | HiProMine S.A. (PL) | 2025-01-29 | — | — | EP | disclosed |
| CN-119192113-A | Pleuromutilin derivative and preparation method and application thereof | 西华大学 | 2024-12-27 | — | — | CN | disclosed |
| US-20240309211-A1 | Composite Wood Board | KNAUF INSULATION SPRL (BE) | 2024-09-19 | — | — | US | disclosed |
| CN-118421507-A | Application of medical cell CMU-Pb-12 combined dexamethasone in preparation of psoriasis prevention and treatment drugs | 广东行海生物科技有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-118421507-A | Application of medical cell CMU-Pb-12 combined dexamethasone in preparation of psoriasis prevention and treatment drugs | 广东行海生物科技有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-118421507-A | Application of medical cell CMU-Pb-12 combined dexamethasone in preparation of psoriasis prevention and treatment drugs | 广东行海生物科技有限公司 | 2024-08-02 | — | — | CN | disclosed |
| US-20160361319-A1 | METHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN AGGREGATION | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2016-12-15 | — | — | US | disclosed |
| US-9452171-B2 | Methods of treating disorders associated with protein aggregation | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2016-09-27 | — | — | US | disclosed |
| US-20150265626-A1 | METHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN AGGREGATION | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2015-09-24 | — | — | US | disclosed |
| US-9072772-B2 | Methods of treating disorders associated with protein aggregation | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2015-07-07 | — | — | US | disclosed |
| US-20140331341-A1 | AUTOMATED HIGH-CONTENT LIVE ANIMAL DRUG SCREENING USING C. ELEGANS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2014-11-06 | — | — | US | disclosed |
| US-20140047569-A9 | Methods of Treating Disorders Associated with Protein Aggregation | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2014-02-13 | — | — | US | disclosed |
| US-20130024953-A1 | Methods of Treating Disorders Associated with Protein Aggregation | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2013-01-24 | — | — | US | disclosed |
| US-8058243-B2 | Method for treating a brain cancer with ifenprodil | HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) | 2011-11-15 | — | — | US | disclosed |
| US-20090076019-A1 | METHODS FOR TREATING NEUROLOGICAL DISORDERS OR DAMAGE | MOUNT SINAI HOSPITAL (CA) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160361319-A1 | METHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN AGGREGATION | HTT, ATIC, API5 | DRD4 3976/4885DRD2 3847/4885CYP1A2 2656/4885 |
| US-20140047569-A9 | Methods of Treating Disorders Associated with Protein Aggregation | HTT, ATIC, API5 | DRD4 3976/4885DRD2 3847/4885CYP1A2 2656/4885 |
| US-20130024953-A1 | Methods of Treating Disorders Associated with Protein Aggregation | HTT, ATIC, API5 | DRD4 3976/4885DRD2 3847/4885CYP1A2 2656/4885 |
| US-20260062742-A1 | RECOMBINANT LIGASES AND USES THEREOF | LIG3, LIG1, LIG4 | DRD4 3059/4885DRD2 3476/4885CYP1A2 3565/4885 |
| US-20260139009-A1 | PREFUSION-STABILIZED CMV GB PROTEINS | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, GHDC, IGF2BP3 | DRD4 2969/4885DRD2 2804/4885CYP1A2 4845/4885 |
| US-20150265626-A1 | METHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN AGGREGATION | HTT, ATIC, API5 | DRD4 3976/4885DRD2 3847/4885CYP1A2 2656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.